Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Evaluation of Respiratory Complications in Patients With X-Linked and Autosomal Recessive Agammaglobulinemia Publisher Pubmed



Fekrvand S1 ; Yazdani R1 ; Olbrich P2 ; Azizi G3 ; Shirzadi R4 ; Modaresi M4 ; Sohani M1 ; Delavari S1 ; Kalantari A5 ; Shariat M6 ; Shafiei A7 ; Lu N8 ; Hassanpour G9 ; Rahimi Hajiabadi M1 Show All Authors
Authors
  1. Fekrvand S1
  2. Yazdani R1
  3. Olbrich P2
  4. Azizi G3
  5. Shirzadi R4
  6. Modaresi M4
  7. Sohani M1
  8. Delavari S1
  9. Kalantari A5
  10. Shariat M6
  11. Shafiei A7
  12. Lu N8
  13. Hassanpour G9
  14. Rahimi Hajiabadi M1
  15. Ashournia P1
  16. Razaghian A1
  17. Asgharyan M1
  18. Shahrakighadimi Z1
  19. Rouhani R1
  20. Hoda Fallah F1
  21. Rezaei N1, 10
  22. Abolhassani H11, 12
  23. Aghamohammadi A1

Source: Pediatric Allergy and Immunology Published:2020


Abstract

Background: Congenital agammaglobulinemia is the first primary immunodeficiency disorder characterized by a defect in B lymphocyte development and subsequently decreased immunoglobulin levels. These patients are prone to suffer from recurrent infections mostly involving the respiratory tract. In this study, we aimed to describe in detail respiratory tract complications as the most prominent clinical feature among agammaglobulinemic patients. Methods: A total number of 115 patients were included. Demographic, clinical, and genetic data were collected from the patients’ medical records. Among the available patients, pulmonary function tests (PFTs) and/or high-resolution computed tomography (HRCT) were performed. Results: Respiratory tract complications (85.2%) especially pneumonia (62.6%) were the most prominent clinical features in our cohort. Among patients with abnormal PFT results (N = 19), a mixed respiratory pattern was observed in 36.8%. HRCT was carried out in 29 patients; Bhalla scoring-based evaluation of these patients indicated excellent (44.8%), followed by good (34.5%) and mild (20.7%) results. Bronchiectasis was found in 13 patients undergoing HRCT (44.8%). We found significant inverse correlations between the Bhalla score and incidence rate of pneumonia, as well as the presence of bronchiectasis. Patients with abnormal PFT results had statistically significant higher bronchiectasis frequency and lower Bhalla scores compared to those with normal results. Forty-one patients were deceased, and here, respiratory failure was the most common cause of death (45.5%). Conclusion: High prevalence of respiratory tract infections among agammaglobulinemic patients and subsequent progression to permanent lung damage highlights the importance of implementing respiratory evaluation as part of routine follow-up program of agammaglobulinemic patients. Physicians should be aware of this and regularly monitor the respiratory function of these patients to allow for timely diagnosis and treatment initiation aiming to improve patients’ prognosis and quality of life. © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
2. Pulmonary Manifestations of Predominantly Antibody Deficiencies, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
Experts (# of related papers)
Other Related Docs
4. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
5. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort, Journal of Allergy and Clinical Immunology: In Practice (2019)
7. Respiratory Complications in Patients With Hyper Igm Syndrome, Journal of Clinical Immunology (2019)
10. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)
11. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
17. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)
20. Evaluation of Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, European Annals of Allergy and Clinical Immunology (2017)